The strongest earnings season in years is coming to a close, and the Wall Street analysts who focus on individual companies have rarely been this bullish. They raised their stock price targets at the fastest pace since the Iran war began as results poured in and continually beat expectations. Cumulatively, they now indicate that the S&P 500 Index will rise 18% from here. Meanwhile, an aggregate of analysts’ profit estimates implies that, at current multiples, the S&P 500 will jump 19% from Friday’s close to end the year above 8,800, amounting to a full-year gain of 29%, which would make it the best year for the index since the 1990s, data compiled by Bloomberg Intelligence show. And there’s only one firm in the S&P 500 with a consensus sell rating. But for the Street’s macro market strategists, who take a broader view of where indexes should be relative to the global economy and external risks, it’s a different story. To them, the war in Iran, a troubling inflation outlook and weak consumer sentiment are crucial metrics that weigh heavily on their predictions. Taken together, they see the S&P 500 ending 2026 at 7,625 , up just 3.3% from where it is now after Friday’s selloff. Historically, a massive difference between the two Wall Street camps foreshadows problems for investors. The trouble this time could be that after a dazzling earnings season where S&P 500 companies posted almost 30% profit growth, blowing past expectations of 12%, single-stock analysts who apply a “bottoms-up” fundamentals-based technique are overlooking key risks that could affect their conclusions. “The bottoms-up analysts are hearing from the CEOs comments like, ‘If we had more compute, there’d be unlimited demand’ or ‘we could make more money, but there’s bottlenecks.’ said Christopher Cain , with Bloomberg Intelligence’s global equity strategy team. “That’s getting the bottoms-up people very bullish.” Rarely have single-stock analysts been this enthusiastic about the S&P 500 relative to th...

The Breakwave Tanker Shipping ETF (NYSEARCA:BWET) has delivered one of the most extreme returns of any U.S.-listed fund in living memory, climbing 1,645% over the past year and 836% year to date to close near $180. Investors hold BWET to bet on crude tanker freight rates through near-dated futures, mostly 90% Very Large Crude Carrier ... BWET’s 1,645% Gain Rests on One Geopolitical Event That Could Reverse in Hours

asbe/iStock via Getty Images Introduction Although macroeconomic uncertainty has risen in recent months, the broader market continues to perform well, with the S&P ( SP500 ) up close to 10% year-to-date at the time of writing. Artificial intelligence continues to fuel much of the rally, and going forward I think this trend could continue. However, investors should be aware that if tensions continue escalating, we could see higher inflation, potentially pressuring the Fed to consider additional tightening. If this occurs, I think we could see a potential market crash or a steep correction, leading to underperformance in the broader market. Long-term investors should view any meaningful pullback as a buying opportunity, particularly in sectors benefitting from AI-driven growth. As a result, I continue to view Invesco's S&P 500 Momentum ETF ( SPMO ) as an attractive long-term investment opportunity, and I believe the fund remains positioned for strong, double-digit return potential ahead. In this article, I discuss recent portfolio changes, the ETF's momentum-driven strategy, and why I believe SPMO is poised to continue outperforming for the foreseeable future. Previous Coverage I last covered SPMO in an article titled: Not So Much Momentum Now, But That's What Makes It A Buy Long-Term. Back in March, the market experienced heightened volatility, mainly centered around rising geopolitical tensions in Iran. This resulted in rising inflation fears, causing SPMO to underperform dividend-focused ETFs like Schwab US Dividend Equity ETF ( SCHD ) & iShares Core Dividend Growth ETF ( DGRO ) in the first 3 months of the year. SPMO's underperformance was a result of modest NAV growth, up less than 1% at the time. Due to rising uncertainty, I believed it was a high possibility of SPMO seeing muted returns in 2026. However, I still believed the ETF was a buy for long-term investors due to its high exposure to the Technology ( XLK ) sector and the likelihood to see AI continue driv...

This Tech Stock Is in a League of Its Own in AI. It's Time to Double Down on It. The Motley Fool

In this article .VIX TLT Follow your favorite stocks CREATE FREE ACCOUNT watch now VIDEO 1:16 01:16 Options Action: Volatility climbs as semiconductors sell off Closing Bell It's been one of the wildest stock markets on record lately but you wouldn't have known it looking at the Cboe Volatility Index . Friday's sell-off just made things a lot clearer. The non-stop, two-month 80% rally in semiconductor stocks that added roughly half a trillion dollars in market cap to the Nasdaq 100 , spurred one of the most successful ETF launches in history, and birthed dozens of eye-popping, parabolic single stock moves, finally hit a wall on Friday as the VanEck Semiconductor ETF (SMH) dropped almost 10% at its low. The VIX, which had just touched the lowest level since January on Thursday, posted its biggest single-day pop since March. S&P 500 index options trading reached a record 7.8 million contracts at Cboe on Friday, 16% higher than the previous record set in April. For many, the sell-off reads as a warning sign for speculative excess in the face of trillions of dollars in upcoming IPO issuance and the potential for rising interest rates. For options traders who had been watching the roller coaster in single stocks, it looks more like an overdue catchup by the broader index. Stock Chart Icon Stock chart icon The Cboe Volatility Index in the past five trading days Coming into this week, a handful of key volatility metrics were at extremes. The spread between single-stock volatility and the broader index reached the widest since Cboe started tracking the data , and one-month implied correlation between the top 50 stocks and the index reached the lowest in a year. It was the VIX slipping below its long-term average that looked the most out of place. "Everything is re-syncing," Brent Kochuba, founder of options analytics platform SpotGamma, said in a call. "The calls were so rich in things like Micron where premiums were bigger than SPY and QQQ combined, this stuff had to come ...

Janice M Hamilton, Chief Financial Officer of Ryan Specialty Holdings (NYSE:RYAN) , reported the open-market purchase of 6,300 shares for a transaction value of approximately $200,000, as disclosed in a SEC Form 4 filing . Transaction value based on SEC Form 4 weighted average purchase price ($31.79); post-transaction value based on June 3, 2026 market close ($31.79). * 1-year price change calculated using June 5, 2026, as the reference date. Continue reading

Key PointsAirJoule announced it was raising capital to bring its water producing systems to market.

Canadian police confirmed Robert Evans Jr pled guilty to the manslaughter of Sharif Rahman while his father and uncle admitted being accessories to the crime.

格隆汇6月6日｜伊朗外交部发表声明，强烈谴责美国军队对位于锡里克地区及格什姆岛的雷达与海岸监测设施实施军事袭击，称这些袭击是对停火协议的公然违反，也是对伊朗主权与领土完整的军事侵略。伊朗外交部指出，美国对停火的反复破坏再次证明，其不仅无意缓和局势、回归稳定轨道，反而通过冒险行为使地区安全面临严重风险。由此产生的一切后果及任何潜在局势升级的责任，均由美国政府承担。伊朗外交部强调伊朗享有固有自卫权，并将动用一切能力与资源捍卫国家主权、安全与国家利益。

atakan/iStock via Getty Images Outlook Therapeutics, Inc. ( OTLK ) has experienced significant price action over the past two weeks, with shares rebounding from a low of $0.23 to $0.84 as of June 1st. The rally has been accompanied by a series of notable developments, including regulatory updates surrounding the company's FDA appeal, news of a secondary offering, and multiple insider purchases. I took a closer look at this nano- to micro-cap company following its recent rally. While concerns surrounding the commercial viability of Lytenava and the company's precarious financial position continue to undermine my long-term confidence, I acknowledge that recent regulatory developments have materially improved the near-term outlook. As a result, I would give a Buy rating, as I believe there is potential upside to the upcoming regulatory catalysts before concerns of commercial viability and balance sheets start to kick in. Niche Market Opportunity with Limited Pricing Power Outlook Therapeutics is a single drug company trying to gain regulatory approval for an ophthalmic formulation of bevacizumab, a mAb that already went generic, for the treatment of wet age-related macular degeneration (AMD). Wet AMD is a progressive eye disease affecting over 20 million populations globally with a market size of $13.8 billion in 2025 and forecasted to grow at a 7.6% CAGR going forward. The primary cause of wet AMD is abnormal blood vessel growth under the retina associated with the overexpression of VEGF protein. Therefore, the predominant first-line treatment is anti-VEGF agents administered intravitreally. The treatment landscape for wet AMD is largely divided into three tiers of anti-VEGF agents. At the premium end are brand names such as Eylea (aflibercept), Vabysmo (faricimab), and Lucentis (ranibizumab), which command a hefty listing price often north of $2000 per single-use vial without specifying doses. In the middle are the biosimilars to ranibizumab and very soon aflibercept...

Long-lasting high gas prices could hurt Walmart's customers and the company's bottom line.

Key PointsWalmart has made strides in attracting higher-income shoppers, but many of its customers are sensitive to higher gas prices.

U.S. EV sales fell 27% in Q1 2026 after federal tax credits ended, creating diverging outlooks for Rivian, Lucid, and Tesla amid continued global EV growth.

格隆汇6月6日｜据俄新社，俄罗斯图门州一座石油炼油厂的火灾已扑灭。

Some patrons of an exclusive Hong Kong sports club have escalated action against the Rosewood Hotel Group’s plan to change operations at its clubhouse in Central, but the hospitality firm says it has made some “refinements” to the arrangement. A representative of a group of concerned patrons at the Hong Kong Golf & Tennis Academy (HKGTA) told the South China Morning Post on Thursday that complaints had been filed with the Consumer Council watchdog. The group had also threatened to take the...

Wachiwit/iStock Editorial via Getty Images A jury in Los Angeles, California, has found that Johnson & Johnson ( JNJ ) was not negligent when ​selling its talc-based cosmetic powder in a lawsuit brought by families of three women who allegedly died due to ovarian cancer after using the company’s talc-based products. Ten of the 12 jurors sided with the healthcare giant in the ruling issued on Friday at the Superior Court of California in Los Angeles, Reuters reported, citing Courtroom View Network. J&J's ( JNJ ) Worldwide Vice President of Litigation Erik Haas welcomed the decision, noting that the lawsuit filed by families of Mary Owens, Bonnie Tienken, and Geneva Williams was based on "junk science." The company is facing tens of thousands of cases claiming that its talc-based product caused ovarian cancer. Trials have resumed after J&J’s ( JNJ ) past attempts to settle through bankruptcy failed. The New Brunswick, New Jersey-based company has resolved a majority of lawsuits alleging that its product led to mesothelioma, a rare cancer associated with asbestos exposure. Almost all remaining cases are related to ovarian cancer claims. More on Johnson & Johnson Why We Increased The Position In Johnson & Johnson Johnson & Johnson (JNJ) Presents at Bernstein 42nd Annual Strategic Decisions Conference Transcript Johnson & Johnson: A Dividend King, But Priced Appropriately, Big Conference Slate Alvotech seeks U.S. nod for biosimilars to J&J’s Simponi and Regeneron’s Eylea again Most and least shorted mid- to mega-cap healthcare stocks at the end of May

'Take The Badge Off': Former Ferrari Boss Slams New $635k EV That Company Thinks Will Attract 'Younger Buyers' One week after Ferrari unveiled its first-ever all-electric car, called the Luce, the design continues to divide analysts. Some referred to the new model as a "mix between a Honda Accord EV and a Tesla," while others said that Tesla's Model S Plaid was far superior. The latest report from Goldman analysts provided new details about their most recent visit to Ferrari's headquarters in Maranello. Last Friday, Ferrari hosted an investor day, which analyst Christian Frenes attended. He spoke with top Ferrari executives just days after the Luce reveal event in Rome earlier in the week. Frenes said management framed the Ferrari Luce as an " additive range model designed to expand the customer base. " He continued: Management reaffirmed the Luce as a strategic entry point to engage new demographics and regions, particularly in markets with higher BEV penetration such as Asia and the Nordics while also targeting a new and younger customer group. The exterior design intentionally distinguishes the EV from existing ICE and PHEV models. Management also reaffirmed it remains aligned with its "technological neutrality" approach continuing to sell V12s and V8s to those interested. Beyond design, Ferrari's battery-powered, four-door, five-seat Luce has another problem : its price tag - a staggering 550,000 euros, or about $638,660. If Ferrari expects that to open the brand to a younger, broader customer base, management certainly has a different view of the world - one that isn't grounded in reality. For starters, Tesla's Model S Plaid costs only a fraction as much and, on key performance metrics , appears to outperform the Luce. The Model S also comes with Full Self-Driving, a feature we are fairly certain Ferrari's first EV lacks. By the end of last week, Ferrari CEO Benedetto Vigna appeared to be on damage-control duty after shares dropped in response to negative inves...

Key PointsDisney's most recent financial results showed strength in experiences, even with inflation rising.

While Starlink soaks up every space headline, two publicly traded satellite operators have quietly turned niche networks into real businesses. I’ve been tracking these names for years, and the setup in 2026 is the most interesting it has ever been: one is being acquired by Amazon (NASDAQ:AMZN), the other is up triple digits year to ... Not SpaceX: The Forgotten Satellite Stocks Quietly Plugging Into the Future of Space That Are Investible Today

Max Zolotukhin/iStock via Getty Images The Bancroft Fund ( BCV ) is a closed-end fund that could present a somewhat appealing investment proposition to those investors who are trying to earn an income and support themselves from the assets in their portfolios. The fund’s current yield of 5.29% is respectable compared to most things in the market, but it is, admittedly, not as high as many other closed-end funds. Fortunately, though, the securities in which the Bancroft Fund invests should be able to deliver better real returns than the securities held in a traditional bond fund. At the same time, the Bancroft Fund has a lower current yield than many bond funds. As such, investors in BCV likely have to give up a bit of current income in exchange for higher total returns. This is not an unreasonable proposition, particularly for those who need their wealth to support them over an extended period of time. About The Bancroft Fund The website for the Bancroft Fund offers the following description of the fund’s strategy and objectives: The Fund’s objectives are providing income and the potential for capital appreciation, by investing in convertible securities. Under normal market conditions, the Fund will invest 65% of its assets in convertible securities. The Fund considers these objectives to be relatively equal, over the long term, due to the nature of the securities in which it invests. This description clearly states that the Bancroft Fund will typically have about 65% of its assets invested in convertible securities, which presumably includes both convertible bonds and convertible preferred stocks. However, as of right now, the fund appears to have a higher level of exposure to these securities. As of the time of writing, the most recent schedule of investments that is available for this fund is found in the semi-annual report for the six-month period that ended on March 31, 2026. This document provides the following asset allocation for the fund as of that date: As...

知情人士称美国政府考虑入股人工智能企业；全球海洋现象智能预报大模型“琅琊”2.0发布...... ①知情人士：美国政府高级官员已与美国大型人工智能企业进行了初步讨论，探讨政府入股这些企业的可能性； ②无锡召开全市集成电路（人工智能）产业发展专题推进会：全力抢抓人工智能发展机遇，统筹抓好“突破高端设计、扩大晶圆制造、提升先进封测、转型装备材料、攻关新兴领域”等重点工作； ③全球海洋现象智能预报大模型“琅琊”2.0发布； ④用友BIP超级版On华为云专属云解决方案发布； ⑤美格智能携手优咔科技发布“端云融合AIoT联合解决方案”。

Assessing Micron Technology (MU) Valuation After A Sharp Pullback In A Strong Year simplywall.st

Key PointsDavid B. Duclos acquired 2,500 shares in an open-market transaction for a total of ~$130,000 on May 28, 2026.

Catch up on all the headlines with BTW. Lisa Mateo, Christina Ruffini and David Gura dive into the headlines you may have missed on Bloomberg This Weekend. Watch the show LIVE every Saturday and Sunday morning: (Source: Bloomberg)

格隆汇6月6日｜欧盟领导人正计划启动一个“渐进式一体化”进程，旨在为欧盟候选成员国提供融入欧盟的经济和政治利益，同时帮助它们度过加入欧盟前的漫长进程。欧盟领导人峰会6月5日在黑山沿海城市蒂瓦特举行。欧盟委员会主席冯德莱恩与德国总理默茨、法国总统马克龙和意大利总理梅洛尼共同表示，欧盟需要“加快并增强扩员进程的可信度”。

guvendemir/iStock Unreleased via Getty Images Introduction Kraft Heinz ( KHC ) owns recognizable brands, still generates cash flow, and still has a dividend yield that will attract income investors. The main problem is the weak earnings trajectory. Kraft Heinz looks cheap on earnings multiples, but this valuation reflects weak organic sales guidance, declining earnings, margin pressure, and a turnaround that’s as of yet unproven. For me, that makes the stock a Sell. Q1 Was Better Than Feared, Not Good Kraft Heinz's first quarter was not a disaster, but it also didn’t show much strength. According to the company’s Q1 2026 prepared remarks, organic net sales declined 0.4%. That was better than management’s initial expectation for a low-single-digit decline, but the quality of the beat was not particularly convincing. The quarter had an estimated 150 basis point consumption benefit from winter storms in January and February. Management described this as a one-off. The underlying volume picture was still weak. Price contributed 0.8 percentage points, while volume/mix declined 1.2%. Management pointed to coffee elasticities and softness in cold cuts as drivers of the volume/mix pressure. North America organic net sales declined 1.1%, with Canada growth more than offset by U.S. weakness, particularly in cold cuts. Profitability also weakened. Adjusted gross profit margin fell 30 basis points to 34.1%, primarily due to inflation, partly offset by productivity gains. Adjusted operating income declined 11.8%, and adjusted EPS declined 6.5% to $0.58. The company beat a low bar, but volume/mix remained negative, and adjusted operating income still fell by double digits. The Problems Extend Beyond Q1 Seeking Alpha The clearest reason to avoid the stock is the earnings outlook. Based on the Seeking Alpha estimate table, Kraft Heinz revenue is expected to fall 2.03% in 2026 to $24.44 billion. Revenue is then expected to rise only 0.45% in 2027. The EPS outlook is even worse, expe...

There's a lot brewing in the U.S. oil and gas sector, and some companies should directly benefit from the next leg of the government's targeted energy expansion.

Google ups the ante in the AI arms race.

Key PointsPresident Donald Trump is overhauling the U.S. energy sector.